Literature DB >> 17075771

Subcutaneous fat modulates insulin sensitivity in mice by regulating TNF-alpha expression in visceral fat.

K Ishikawa1, K Takahashi, H Bujo, N Hashimoto, K Yagui, Y Saito.   

Abstract

The distribution of fat in obese persons is related to the risk of developing various metabolic disorders, such as glucose intolerance, dyslipidemia and hypertension, and the combination of these conditions is known as the metabolic syndrome. The aim of this study was to investigate the role of subcutaneous fat in regulating insulin resistance and its influence on TNF-alpha expression in visceral fat, by using mice that were subjected to subcutaneous lipectomy with or without subsequent fat transplantation. After partial subcutaneous lipectomy, mice showed significantly greater accumulation of visceral fat compared with sham-operated control mice. Lipectomy led to higher plasma insulin and lower plasma glucose levels after loading with glucose and insulin, respectively, compared with the levels in control mice. Insulin-induced phosphorylation of IRS-1 was decreased in the skeletal muscles of lipectomized mice. Subcutaneous transplantation of fat pads into lipectomized mice reversed the above-mentioned changes indicating insulin resistance in these animals. The fat storage area of adipocytes and TNF- alpha expression by adipocytes in visceral fat were significantly higher in the lipectomized mice than in controls, while subcutaneous transplantation of fat reduced both the fat storage area and TNF-alpha expression. The insulin resistance of lipectomized mice was also ameliorated by systemic neutralization of TNF-alpha activity using a specific antibody. These findings obtained in mice subjected to subcutaneous lipectomy with/without subsequent fat transplantation indicate that subcutaneous fat regulates systemic insulin sensitivity, possibly through altering fat storage and the expression of TNF-alpha by adipocytes in visceral fat. The balance between accumulation of subcutaneous fat and visceral fat may be important with respect to the occurrence of systemic insulin resistance in the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075771     DOI: 10.1055/s-2006-954580

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  13 in total

1.  A dysregulation in CES1, APOE and other lipid metabolism-related genes is associated to cardiovascular risk factors linked to obesity.

Authors:  M Pilar Marrades; Pedro González-Muniesa; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Obes Facts       Date:  2010-10-15       Impact factor: 3.942

2.  Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome.

Authors:  Thomas C Wascher; Jan H N Lindeman; Harald Sourij; Teake Kooistra; Giovanni Pacini; Michael Roden
Journal:  Mol Med       Date:  2010-11-16       Impact factor: 6.354

3.  Lower body adipose tissue removal decreases glucose tolerance and insulin sensitivity in mice with exposure to high fat diet.

Authors:  K Cox-York; Y Wei; D Wang; M J Pagliassotti; M T Foster
Journal:  Adipocyte       Date:  2014-12-20       Impact factor: 4.534

Review 4.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

Review 5.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

6.  Insulin sensitivity in African-American and white women: association with inflammation.

Authors:  Tanya C Hyatt; Radhika P Phadke; Gary R Hunter; Nikki C Bush; A Julian Muñoz; Barbara A Gower
Journal:  Obesity (Silver Spring)       Date:  2008-11-27       Impact factor: 5.002

Review 7.  Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.

Authors:  Meric Erikci Ertunc; Gökhan S Hotamisligil
Journal:  J Lipid Res       Date:  2016-06-21       Impact factor: 5.922

8.  PAPPA-mediated adipose tissue remodeling mitigates insulin resistance and protects against gestational diabetes in mice and humans.

Authors:  Raziel Rojas-Rodriguez; Rachel Ziegler; Tiffany DeSouza; Sana Majid; Aylin S Madore; Nili Amir; Veronica A Pace; Daniel Nachreiner; David Alfego; Jomol Mathew; Katherine Leung; Tiffany A Moore Simas; Silvia Corvera
Journal:  Sci Transl Med       Date:  2020-11-25       Impact factor: 17.956

9.  Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity.

Authors:  Ko Ishikawa; Koutaro Yokote
Journal:  J Diabetes Investig       Date:  2014-03-13       Impact factor: 4.232

10.  Subcutaneous Adipose Tissue Transplantation in Diet-Induced Obese Mice Attenuates Metabolic Dysregulation While Removal Exacerbates It.

Authors:  M T Foster; S Softic; J Caldwell; R Kohli; A D de Kloet; R J Seeley
Journal:  Physiol Rep       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.